ProSomnus (ProSomnus) 12-1 Month Momentum % : -89.40% (As of May. 15, 2024)

View and export this data going back to 2022. Start your Free Trial

What is ProSomnus 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-15), ProSomnus's 12-1 Month Momentum % is -89.40%.

The industry rank for ProSomnus's 12-1 Month Momentum % or its related term are showing as below:

OSAPQ's 12-1 Month Momentum % is ranked worse than
96.72% of 853 companies
in the Medical Devices & Instruments industry
Industry Median: -16.72 vs OSAPQ: -89.40

Competitive Comparison of ProSomnus's 12-1 Month Momentum %

For the Medical Devices subindustry, ProSomnus's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ProSomnus's 12-1 Month Momentum % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ProSomnus's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where ProSomnus's 12-1 Month Momentum % falls into.

ProSomnus (OTCPK:OSAPQ) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %

( Price 1-month ago

Price 12-month ago

- 1 )

100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ProSomnus (OTCPK:OSAPQ) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

ProSomnus 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of ProSomnus's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.

ProSomnus (ProSomnus) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ProSomnus Inc (OTCPK:OSAPQ) » Definitions » 12-1 Month Momentum %

Comparable Companies

Traded in Other Exchanges

N/A

Address

5675 Gibraltar Drive, Pleasanton, CA, USA, 94588

Website

https://www.prosomnus.com

ProSomnus Inc is a medical device manufacturer. It manufacturers precision, mass-customized oral appliance therapy devices to treat obstructive sleep apnea, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus's patented devices are more comfortable and less invasive alternative to continuous positive airway pressure therapy, and lead to more effective and patient-preferred outcomes.

Executives

Sung Kim	officer: Chief Technical Officer	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
John Steffens	10 percent owner	C/O DIGITALBRIDGE GROUP, INC., 750 PARK OF COMMERCE DRIVE SUITE 210, BOCCA RATON FL 33487
Gregory P. Ho	10 percent owner	C/O SPRING MOUNTAIN CAPITAL, LP, 650 MADISON AVENUE, 20TH FLOOR, NEW YORK NY 10022
Brian B Dow	officer: Chief Financial Officer	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Smc Holdings Ii, Lp	10 percent owner	65 EAST 55TH STREET, 33RD FLOOR, NEW YORK NY 10022
Smc Holdings Ii G.p., Llc	10 percent owner	C/O SPRING MOUNTAIN CAPITAL, LP, 650 MADISON AVENUE, 20TH FLOOR, NEW YORK NY 10022
Laing Rikkers	director	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Len Liptak	director, officer: Chief Executive Officer	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Mark Thomas Murphy	officer: Chief Growth Officer	5675 GIBRALTAR AVENUE, PLEASANTON CA 94588
Hgp Iii, Llc	10 percent owner	3708 ASHFORD PLACE, GREENVILLE NC 27858
Steven Robert Pacelli	director	5555 OBERLIN DRIVE, SAN DIEGO CA 92121
Hmc, Llc	10 percent owner	3708 ASHFORD PLACE, GREENVILLE NC 27858
Healthpointcapital, Llc	10 percent owner	C/O HEALTHPOINTCAPITAL, 505 PARK AVENUE, 12TH FLOOR, NEW YORK NY 10022
Healthpointcapital Partners Iii Lp	10 percent owner	505 Park Avenue, 12th Floor, New York NY 10022
Leonard Hedge	director	7855 BELLA MONTANIA LANE, PALO CEDRO CA 96073